Christopher Matheny
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- HER2/EGFR in Cancer Research
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 6
- HER2/EGFR in Cancer Research 4
- Drug Transport and Resistance Mechanisms 4
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Gary M. Pollack (3 shared papers)Kim L. R. Brouwer (2 shared papers)Matthew W. Lamb (1 shared paper)Xiaodong Yang (1 shared paper)Jonathan Larkin (2 shared papers)Liangfu Chen (2 shared papers)Harma Ellens (2 shared papers)Stéphane Mouly (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2 papers)Osteoarthritis and Cartilage (2 papers)Drug Metabolism and Disposition (2 papers)Journal of Thoracic Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Christopher Matheny
23 papers receiving 678 citations
Peers
Comparison fields: 5 of 86
- Pharmacology 122
- Oncology 356
- Rheumatology 113
- Pediatrics, Perinatology and Child Health 139
- Immunology and Allergy 41
Countries citing papers authored by Christopher Matheny
This map shows the geographic impact of Christopher Matheny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Matheny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Matheny more than expected).
Fields of papers citing papers by Christopher Matheny
This network shows the impact of papers produced by Christopher Matheny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Matheny. The network helps show where Christopher Matheny may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Matheny, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 167 | |
| 2 | 2015 | 103 | |
| 3 | 2005 | 73 | |
| 4 | 2004 | 59 | |
| 5 | 2019 | 58 | |
| 6 | 2014 | 39 | |
| 7 | 2016 | 35 | |
| 8 | 2017 | 27 | |
| 9 | 2021 | 27 | |
| 10 | 2000 | 23 | |
| 11 | 2020 | 17 | |
| 12 | 2022 | 12 | |
| 13 | 2013 | 11 | |
| 14 | 2014 | 9 | |
| 15 | 2018 | 8 | |
| 16 | 2018 | 6 | |
| 17 | ImmunoPET imaging to assess target engagement: Experience from Zr-89-anti-HER3 mAb (GSK2849330) in patients with solid tumors | 2017 | 5 |
| 18 | 2017 | 5 | |
| 19 | 1999 | 4 | |
| 20 | 1996 | 2 |
About Christopher Matheny
Christopher Matheny is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Immunology, Surgery and Molecular Biology, having authored 23 papers that have together received 695 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), HER2/EGFR in Cancer Research (4 papers), Immune Response and Inflammation (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Pharmacological Effects and Toxicity Studies (3 papers), Cancer Research and Treatments (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Pharmacology (122 citations), Oncology (356 citations), Rheumatology (113 citations), Pediatrics, Perinatology and Child Health (139 citations) and Immunology and Allergy (41 citations). Christopher Matheny has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Gary M. Pollack, Kim L. R. Brouwer, Matthew W. Lamb, Xiaodong Yang, Jonathan Larkin, Liangfu Chen, Harma Ellens, Stéphane Mouly, Anne‐Marie Malfait and Jean Shearin. Their work appears in journals such as Journal of Clinical Oncology, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Osteoarthritis and Cartilage, Drug Metabolism and Disposition and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.